Wuhan Financial Statements From 2010 to 2025
| 300871 Stock | 11.38 0.09 0.80% |
Check Wuhan Hvsen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Wuhan Hvsen's main balance sheet or income statement drivers, such as , as well as many indicators such as . Wuhan financial statements analysis is a perfect complement when working with Wuhan Hvsen Valuation or Volatility modules.
Wuhan |
Wuhan Hvsen Biotechnology Company Current Valuation Analysis
Wuhan Hvsen's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Wuhan Hvsen Current Valuation | 2.33 B |
Most of Wuhan Hvsen's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Wuhan Hvsen Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Wuhan Hvsen Biotechnology has a Current Valuation of 2.33 B. This is 83.79% lower than that of the Biotechnology sector and 49.88% lower than that of the Health Care industry. The current valuation for all China stocks is 85.99% higher than that of the company.
Wuhan Hvsen Biotechnology Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Wuhan Hvsen's current stock value. Our valuation model uses many indicators to compare Wuhan Hvsen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Wuhan Hvsen competition to find correlations between indicators driving Wuhan Hvsen's intrinsic value. More Info.Wuhan Hvsen Biotechnology is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Wuhan Hvsen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Wuhan Hvsen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Wuhan Hvsen Financial Statements
Wuhan Hvsen stakeholders use historical fundamental indicators, such as Wuhan Hvsen's revenue or net income, to determine how well the company is positioned to perform in the future. Although Wuhan Hvsen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Wuhan Hvsen's assets and liabilities are reflected in the revenues and expenses on Wuhan Hvsen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Wuhan Hvsen Biotechnology. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Wuhan Stock
Wuhan Hvsen financial ratios help investors to determine whether Wuhan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Wuhan with respect to the benefits of owning Wuhan Hvsen security.